Amanda M. Brown

Last updated
Amanda M. Brown
Amanda Brown speaks at NIHNINDS.jpg
Brown speaks at the National Institute of Neurological Disorders and Stroke in 2018
NationalityAmerican
Alma mater University of California, Riverside
Albert Einstein College of Medicine
Aaron Diamond AIDS Research Center
Known forFirst cloning of recombinant HIV virus with GFP tag
Awards2018 Johns Hopkins University School of Medicine Living the Hopkins Mission Honor, 2014 Keystone Symposia on Molecular and Cell Biology Fellow, 2014 Johns Hopkins Diversity Leadership Award
Scientific career
Fields Neuroimmunology
Institutions Johns Hopkins University School of Medicine

Amanda Brown is an American immunologist and microbiologist as well as an associate professor of neurology and neuroscience at Johns Hopkins University School of Medicine in Baltimore, Maryland. Brown is notable for cloning one of the first recombinant HIV viruses [1] and developing a novel method to visualize HIV infected cells using GFP fluorescence.

Contents

As a principal investigator at Johns Hopkins, Brown studies HIV in the central nervous system, focusing on the cellular role of osteopontin in regulating inflammatory signalling pathways in HIV infected macrophages. Brown also explores how microglia and macrophages serve as latent viral reservoirs in order to target these mechanisms to prevent HIV-associated neurocognitive disorder. In addition to her research, Brown mentors and recruits the future cohort of diverse leaders in STEM, serving as director of the Johns Hopkins Neuroscience Scholars Program, and for 10 years serving as program director for the Department of Neurology Johns Hopkins Internship in Brain Sciences Program for Baltimore City High School Students.

Early life and education

Brown pursued her undergraduate degree at the University of California, Riverside in 1985. [2] She majored in Biochemistry and graduated with a Bachelor of Science in 1989. [2] After her undergraduate degree, Brown began her graduate studies at Albert Einstein College of Medicine, where she completed her PhD in microbiology and immunology. [3] She studied under the mentorship of William R. Jacobs. [2] During her PhD, she became interested in macrophage-pathogen biology and was selected to take a Cold Spring Harbor Course on Advanced Bacterial Genetics. [4]

Brown helped to develop a novel method to study the mechanisms underlying mycobacterium replication in mononuclear phagocytes. [5] Brown and her colleagues developed a leucine auxotrophic mutant that the field could use to study the host-pathogen interactions of mycobacterium and the animal cells thy replicate in. [5] Brown also explored the sec-dependent protein export pathway in mycobacterium, the main protein export pathway into the cytoplasm, and discovered the presence of two homologues of the SecA protein. [6]  SecA1 they found to be essential, but SecA2 they found to be nonessential but conserved across mycobacteria suggesting its alternate and unknown roles in pathogenesis and mycobacterium physiology. [6]

Development of recombinant HIV reporter tool

Brown completed her PhD in 1996, and continued to study intracellular pathogens that are able to evade the immune response. [2]  Brown pursued her postdoctoral training at the Aaron Diamond AIDS Research Center in New York City, where she studied under the mentorship of Cecilia Cheng-Meyer. [3] During her postdoctoral studies Brown led the cloning of the first recombinant HIV virus that enabled the visualization of HIV infected cells by expressing green fluorescent protein. [1] She later used this technology to explore the role of HIV protein Nef in pathogenesis, finding that Nef's interaction with cellular kinases enables the removal of CD4 from the surface of infected macrophages. [7] Brown also used this fluorescent tool to discover that HLA-A2 is down-regulated in HIV infected macrophages. [8] Further, Brown was the first to model the HIV-macrophage reservoir using her fluorescent tagging tool, and this method continues to be used today to study latent HIV infection. [9]

From 1999 to 2003, Brown completed a second postdoctoral fellowship at Johns Hopkins University School of Medicine in Baltimore, Maryland. [2] She worked under Suzanne Gartner in the Department of Neurology studying HIV infection in macrophages, with a focus on the infection of macrophages in the brain, namely microglia. [9]

Career and research

In 2007, Brown became an instructor in the Department of Neurology, and in 2010 Brown was appointed to the faculty at Johns Hopkins University School of Medicine, where she became an assistant professor of neurology in the Department of Neurology. [4] In 2016, Brown was promoted to associate professor in the Department of Neurology. [10] As the principal investigator of the Brown Laboratory Research Group, Brown explores how HIV infection persists in macrophages and how the chronic inflammatory response, as a result of infection, leads to neuronal damage and neurodegeneration. [10]

Academic leadership

In addition to her research, Brown has held many leadership positions at Johns Hopkins School of Medicine. In 2015, Brown established the Neurosciences Community Innovation Council and became vice chair of the department. [11] Brown is also the co-director of the Developmental Core for the NIMH Johns Hopkins Center for Novel Therapeutics for HIV-Associated Cognitive Disorders. [12] During the COVID-19 pandemic, Brown was elected a member of the Johns Hopkins University School of Medicine Pandemic Academic Advisory Committee. [13]

Education and outreach leadership

Brown also serves as a director of the Hopkins NeuroHIV-Comorbidities Scholars program [14] and also Directs the Translational Research in Neuro-AIDS and Mental Health program at Johns Hopkins School of Medicine. [15] Brown secured an R25 grant from the National Institutes of Health to run this program which educates research across the United States and internationally about the effects of HIV infection in racial and ethnic minority populations. [16]

Brown was also the director of the Johns Hopkins Internship in Brain Sciences (JHIBS) Program, also supported by the NIH R25 grant that Brown obtained. [17] The JHIBS program recruits underrepresented minority high school students in the Baltimore area to experience research as a paid intern for 8 weeks at JHSOM. [18] Over 150 high school students have participated in the program throughout Brown's leadership tenure and the students have an 84% matriculation rate into college. [11]

Brown, with the help of Tilak Ratnanather, founded the Johns Hopkins Neuroscience Scholars Program which helps to recruit and retain underrepresented minority students in neuroscience and is funded by the National Institutes of Neurological Disorders and Stroke. [19] This national program focused on mentoring underrepresented and deaf or hard-of-hearing undergraduates to obtain career development and research exposure in neuroscience. [20]

Osteopontin signalling in HIV infection of the central nervous system

Brown focuses her research program on studying the role of osteopontin in HIV pathogenesis in the central nervous system. Osteopontin is a pro-inflammatory cytokine that is secreted by the two main cells in the brain that HIV infects, namely T cells and macrophages. [21] Brown found, in 2011, that osteopontin enhances HIV replication and is overall increased in the brains of HIV infected individuals. [22] Further exploring its mechanisms of action, Brown discovered in 2020 that osteopontin may exert protective functions in the CNS through interacting with components of the extracellular matrix to active downstream protective signalling. [23]

Awards and honors

Related Research Articles

<span class="mw-page-title-main">HIV</span> Human retrovirus, cause of AIDS

The human immunodeficiency viruses (HIV) are two species of Lentivirus that infect humans. Over time, they cause acquired immunodeficiency syndrome (AIDS), a condition in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype.

<span class="mw-page-title-main">Whipple's disease</span> Medical condition

Whipple's disease is a rare systemic infectious disease caused by the bacterium Tropheryma whipplei. First described by George Hoyt Whipple in 1907 and commonly considered as a gastrointestinal disorder, Whipple's disease primarily causes malabsorption, but may affect any part of the human body, including the heart, brain, joints, skin, lungs and the eyes. Weight loss, diarrhea, joint pain, and arthritis are common presenting symptoms, but the presentation can be highly variable in certain individuals, and about 15% of patients do not have the standard signs and symptoms.

<span class="mw-page-title-main">Asymptomatic carrier</span> Organism which has become infected with a pathogen but displays no symptoms

An asymptomatic carrier is a person or other organism that has become infected with a pathogen, but shows no signs or symptoms.

HIV-associated neurocognitive disorders (HAND) are neurological disorders associated with HIV infection and AIDS. It is a syndrome of progressive deterioration of memory, cognition, behavior, and motor function in HIV-infected individuals during the late stages of the disease, when immunodeficiency is severe. HAND may include neurological disorders of various severity. HIV-associated neurocognitive disorders are associated with a metabolic encephalopathy induced by HIV infection and fueled by immune activation of macrophages and microglia. These cells are actively infected with HIV and secrete neurotoxins of both host and viral origin. The essential features of HIV-associated dementia (HAD) are disabling cognitive impairment accompanied by motor dysfunction, speech problems and behavioral change. Cognitive impairment is characterised by mental slowness, trouble with memory and poor concentration. Motor symptoms include a loss of fine motor control leading to clumsiness, poor balance and tremors. Behavioral changes may include apathy, lethargy and diminished emotional responses and spontaneity. Histopathologically, it is identified by the infiltration of monocytes and macrophages into the central nervous system (CNS), gliosis, pallor of myelin sheaths, abnormalities of dendritic processes and neuronal loss.

<span class="mw-page-title-main">Meningoencephalitis</span> Medical condition

Meningoencephalitis, also known as herpes meningoencephalitis, is a medical condition that simultaneously resembles both meningitis, which is an infection or inflammation of the meninges, and encephalitis, which is an infection or inflammation of the brain tissue.

Sulfatide, also known as 3-O-sulfogalactosylceramide, SM4, or sulfated galactocerebroside, is a class of sulfolipids, specifically a class of sulfoglycolipids, which are glycolipids that contain a sulfate group. Sulfatide is synthesized primarily starting in the endoplasmic reticulum and ending in the Golgi apparatus where ceramide is converted to galactocerebroside and later sulfated to make sulfatide. Of all of the galactolipids that are found in the myelin sheath, one fifth of them are sulfatide. Sulfatide is primarily found on the extracellular leaflet of the myelin plasma membrane produced by the oligodendrocytes in the central nervous system and in the Schwann cells in the peripheral nervous system. However, sulfatide is also present on the extracellular leaflet of the plasma membrane of many cells in eukaryotic organisms.

Host tropism is the infection specificity of certain pathogens to particular hosts and host tissues. This explains why most pathogens are only capable of infecting a limited range of host organisms.

Visna-maedi virus from the genus Lentivirus and subfamily Orthoretrovirinae, is a retrovirus that causes encephalitis and chronic pneumonitis in sheep. It is known as visna when found in the brain, and maedi when infecting the lungs. Lifelong, persistent infections in sheep occur in the lungs, lymph nodes, spleen, joints, central nervous system, and mammary glands; The condition is sometimes known as ovine progressive pneumonia (OPP), particularly in the United States, or Montana sheep disease. White blood cells of the monocyte/macrophage lineage are the main target of the virus.

<span class="mw-page-title-main">Janice E. Clements</span> American biologist, academic and medical researcher

Janice Ellen Clements is vice dean for faculty at the Johns Hopkins School of Medicine and the Mary Wallace Stanton Professor of Faculty Affairs. She is a professor in the departments of Molecular and Comparative Pathobiology, Neurology, and Pathology, and has a joint appointment in molecular biology and genetics. Her molecular biology and virology research examines lentiviruses and how they cause neurological diseases.

M. Christine "Chris" Zink is the director of the Department of Molecular and Comparative Pathobiology at the Johns Hopkins School of Medicine. She also holds professorships in the Department of Pathology at Johns Hopkins and in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. Zink researches the response of the immune system to retroviruses such as HIV and is currently investigating an animal model of antiretroviral therapy and the potential of a common antibiotic to prevent HIV-associated neurocognitive disorders.

Neurovirology is an interdisciplinary field which represents a melding of clinical neuroscience, virology, immunology, and molecular biology. The main focus of the field is to study viruses capable of infecting the nervous system. In addition to this, the field studies the use of viruses to trace neuroanatomical pathways, for gene therapy, and to eliminate detrimental populations of neural cells.

<span class="mw-page-title-main">Gladstone Institutes</span>

Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.

<span class="mw-page-title-main">Signs and symptoms of HIV/AIDS</span>

The stages of HIV infection are acute infection, latency, and AIDS. Acute infection lasts for several weeks and may include symptoms such as fever, swollen lymph nodes, inflammation of the throat, rash, muscle pain, malaise, and mouth and esophageal sores. The latency stage involves few or no symptoms and can last anywhere from two weeks to twenty years or more, depending on the individual. AIDS, the final stage of HIV infection, is defined by low CD4+ T cell counts, various opportunistic infections, cancers, and other conditions.

<span class="mw-page-title-main">Lalita Ramakrishnan</span> Indian-American microbiologist

Lalita Ramakrishnan is an Indian-born American microbiologist who is known for her contributions to the understanding of the biological mechanism of tuberculosis. As of 2019 she serves as a professor of Immunology and Infectious Diseases at the University of Cambridge, where she is also a Wellcome Trust Principal Research Fellow and a practicing physician. Her research is conducted at the MRC Laboratory of Molecular Biology, where she serves as the Head of the Molecular Immunity Unit of the Department of Medicine embedded at the MRC LMB. Working with Stanley Falkow at Stanford, she developed the strategy of using Mycobacterium marinum infection as a model for tuberculosis. Her work has appeared in a number of journals, including Science, Nature, and Cell. In 2018 and 2019 Ramakrishnan coauthored two influential papers in the British Medical Journal (BMJ) arguing that the widely accepted estimates of the prevalence of latent tuberculosis—estimates used as a basis for allocation of research funds—are far too high. She is married to Mark Troll, a physical chemist.

<span class="mw-page-title-main">Henry Mwandumba</span> African professor of medicine

Henry Charles Mwandumba is an African Professor of Medicine and the Director of the Malawi-Liverpool-Wellcome Programme. He works on the tuberculosis phagosome in the University of Malawi College of Medicine, and serves as President of the Federation of African Immunological Societies. In 2019 Mwandumba was awarded the Royal Society Africa Prize.

Ya-Chi Ho is a Taiwanese infectious disease researcher and Associate Professor of Microbial Pathogenesis and Medicine at Yale University. Her research centers on the interaction between HIV and the host's immune system with the ultimate goal of curing HIV/AIDS.

Georgette D. Kanmogne is a Cameroonian American geneticist and molecular virologist and a full professor and vice chair for resource allocation and faculty development within the Department of Pharmacology and Experimental Neurosciences at the University of Nebraska Medical Center in Omaha, Nebraska. Kanmogne's research program focuses on exploring the pathogenesis of neuroAIDS by deciphering the mechanisms underlying blood brain barrier dysfunction and viral entry into the central nervous system. Her research also addresses the lack of HIV therapies that cross the blood brain barrier (BBB) and has played a critical role in the development of nanoparticles encapsulating HIV-drugs that can cross the BBB to prevent viral-mediated neuron death in the brain. Kanmogne collaborates with clinical and basic researchers across America, Cameroon, and West Africa, spanning disciplines from hematology to psychiatry, to explore how viral genetic diversity is correlated with the neurological impact of HIV.

Crystal C. Watkins Johansson is an American neuroscientist and psychiatrist and associate professor of neuroscience at Johns Hopkins University School of Medicine as well as the director of the Sheppard Pratt Memory Clinic in Neuropsychiatry in Baltimore, Maryland. Johansson was the first Black female Meyerhoff Scholar to obtain an MD/PhD from the University of Maryland, Baltimore County. During her MD/PhD she developed a novel treatment for gastrointestinal in patients with diabetes that led to a patent for a pharmacological compound in 2000. Johansson is a practicing neuropsychiatrist with a focus on geriatric psychiatry and she conducts brain imaging research as well as research on cancer in African American women.

<span class="mw-page-title-main">Ava Easton</span>

Ava Easton is a health scientist and researcher who specialises in encephalitis, acquired brain injury and narrative medicine, and is considered a world expert in her field of Encephalitis patient outcomes and quality of life. She is the current Chief Executive of The Encephalitis Society, a non-profit organisation which provides support and resources for those affected by the neurological disease of Encephalitis, and collaborates with various organisations on research into the disease.

Howard E. Gendelman is an American physician-scientist whose research intersects the disciplines of neuroimmunology, pharmacology, and infectious diseases. Gendelman was born in Philadelphia, Pennsylvania. His research is focused on harnessing immune responses for therapeutic gain in HIV/AIDS and Neurodegenerative disease. He is the Margaret R. Larson Professor of infectious diseases and internal medicine at the University of Nebraska Medical Center (UNMC) in Omaha.

References

  1. 1 2 Brown, Amanda M. (2009). "Use of a Macrophage-Tropic GFP-Tagged Human Immunodeficiency Virus Type 1 (HIV-1) to Study Viral Reservoirs". Viral Applications of Green Fluorescent Protein. Methods in Molecular Biology. Vol. 515. pp. 165–175. doi:10.1007/978-1-59745-559-6_11. ISBN   978-1-934115-87-9. ISSN   1064-3745. PMID   19378134.
  2. 1 2 3 4 5 "Amanda M. Brown, Ph.D., Associate Professor of Neurology". Johns Hopkins Medicine. Retrieved 2020-06-28.
  3. 1 2 "Meet the W&D Committee". leukocytebiology.org. Archived from the original on 2019-12-29. Retrieved 2020-06-28.
  4. 1 2 "On Fire: HIV in the Brain- Taming the Flame". ninds.nih.gov. 2019. Archived from the original on 2019-04-10. Retrieved June 27, 2020.
  5. 1 2 Bange, Franz Christoph; Brown, Amanda M.; Jacobs, William R. (1996-01-01). "Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages". Infection and Immunity. 64 (5): 1794–1799. doi:10.1128/iai.64.5.1794-1799.1996. ISSN   0019-9567. PMC   173994 . PMID   8613393.
  6. 1 2 Braunstein, M.; Brown, A. M.; Kurtz, S.; Jacobs, W. R. (December 2001). "Two nonredundant SecA homologues function in mycobacteria". Journal of Bacteriology. 183 (24): 6979–6990. doi:10.1128/JB.183.24.6979-6990.2001. ISSN   0021-9193. PMC   95544 . PMID   11717254.
  7. ↑ Brown, Amanda; Moghaddam, Shaghayegh; Kawano, Thomas; Cheng-Mayer, Cecilia (June 2004). "Multiple human immunodeficiency virus type 1 Nef functions contribute to efficient replication in primary human macrophages". The Journal of General Virology. 85 (Pt 6): 1463–1469. doi: 10.1099/vir.0.79946-0 . ISSN   0022-1317. PMID   15166429.
  8. ↑ Brown, Amanda; Gartner, Suzanne; Kawano, Thomas; Benoit, Nicole; Cheng-Mayer, Cecilia (September 2005). "HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus". Journal of Leukocyte Biology. 78 (3): 675–685. doi: 10.1189/jlb.0505237 . ISSN   0741-5400. PMID   16000390.
  9. 1 2 Brown, Amanda; Zhang, Hao; Lopez, Peter; Pardo, Carlos A.; Gartner, Suzanne (November 2006). "In vitro modeling of the HIV-macrophage reservoir". Journal of Leukocyte Biology. 80 (5): 1127–1135. doi: 10.1189/jlb.0206126 . ISSN   0741-5400. PMID   16923921. S2CID   14355067.
  10. 1 2 3 4 "About | Best Neuroscience Program | JHNSP". Johns Hopkins Neuroscience Scholars Program. Retrieved 2020-06-28.
  11. 1 2 3 "Living the Hopkins Mission Honorees". www.hopkinsmedicine.org. Retrieved 2020-06-28.
  12. ↑ "Development Core | Johns Hopkins NIMH Center". www.hopkinsmedicine.org. Retrieved 2020-06-28.
  13. ↑ "University Pandemic Academic Advisory Committee". The Hub. Retrieved 2020-06-28.
  14. ↑ "Amanda Brown". neuroscience.jhu.edu. Retrieved 2020-06-28.
  15. ↑ "Translational Research in Neuro-AIDS and Mental Health" (PDF). cfar.globalhealth.harvard.edu. 2014. Retrieved June 27, 2020.
  16. ↑ Brown, Amanda. "The Johns Hopkins NeuroHIV Comorbidities Scholar Program".{{cite journal}}: Cite journal requires |journal= (help)
  17. ↑ "Past Intern Research Projects | Johns Hopkins Internship in Brain Sciences". www.hopkinsmedicine.org. Retrieved 2020-06-28.
  18. ↑ "Overview". Johns Hopkins Internship in Brain Sciences. 2015-06-15. Retrieved 2020-06-28.
  19. ↑ "Charles Wiener named president of Johns Hopkins Medicine International". The Hub. 2018-12-20. Retrieved 2020-06-28.
  20. ↑ "Johns Hopkins Neuroscience Scholars Program". www.pathwaystoscience.org. Retrieved 2020-06-28.
  21. ↑ Brown, Amanda (2012-02-01). "Osteopontin: A key link between immunity, inflammation and the central nervous system". Translational Neuroscience. 3 (3): 288–293. doi:10.2478/s13380-012-0028-7. ISSN   2081-3856. PMC   3616337 . PMID   23565338.
  22. ↑ Brown, Amanda; Islam, Tanzeem; Adams, Robert; Nerle, Sujata; Kamara, Masiray; Eger, Caitlin; Marder, Karen; Cohen, Bruce; Schifitto, Giovanni; McArthur, Justin C.; Sacktor, Ned (August 2011). "Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals". Journal of Neurovirology. 17 (4): 382–392. doi:10.1007/s13365-011-0035-4. ISSN   1538-2443. PMC   3331788 . PMID   21556958.
  23. ↑ Mahmud, Farina J.; Boucher, Thomas; Liang, Shijun; Brown, Amanda M. (2020-06-04). "Osteopontin and Integrin Mediated Modulation of Post-Synapses in HIV Envelope Glycoprotein Exposed Hippocampal Neurons". Brain Sciences. 10 (6): 346. doi: 10.3390/brainsci10060346 . ISSN   2076-3425. PMC   7349055 . PMID   32512754.
  24. ↑ "YouTube". www.youtube.com. Retrieved 2020-06-28.
  25. ↑ "Cheers". The Hub. 2014-07-01. Retrieved 2020-06-28.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.